Abstract
Collecting duct carcinoma (CDC) is rare and aggressive histology of kidney cancers. Although different therapeutic approaches have been tested, the 2-year survival remains very poor. Since CDC exhibits overlapping features with urothelial carcinoma, the analysis of shared molecular alterations could provide new insights into the understanding of this rare disease and also therapeutic options. We collected 26 CDC cases, and we assessed HER2 protein expression by immunohistochemistry (IHC) and gene amplification by fluorescence in-situ hybridization (FISH) according to 2018 ASCO/CAP HER2-testing recommendations. Six out of twenty-six (23%) tumors showed HER2 positive staining. In particular, 3+ score was present in 2/6 cases (33%), 2+ in 3/6 cases (50%) and 1+ in 1/6 cases (17%). The 6 HER2+ tumors were also analyzed by FISH to assess gene copy number. One out of six CDC with IHC 3+ was also HER2 amplified, showing an average HER2 copy number ≥4.0 (10.85) and a HER2/CEP17 ratio ≥ (5.63), while the 5/6 cases were HER2 negative. Based on the 2018 ASCO/CAP guidelines overall, 2/26 CDC cases (8%) were HER2+. The present study provides evidence for testing, in future studies, HER2 to assess its clinical value as a novel target for the...Continue Reading
References
Jul 1, 1997·The Journal of Urology·C SelliC Orlando
Dec 13, 2005·The New England Journal of Medicine·Herbert T Cohen, Francis J McGovern
Jun 7, 2006·The Journal of Urology·Noriaki TokudaUNKNOWN Japanese Society of Renal Cancer
Sep 19, 2008·Journal of Medical Case Reports·Hisao NakamuraYasuo Nakajima
Dec 5, 2012·Onkologie·Miguel H BronchudXavier Andreu
Jun 6, 2013·Current Oncology·S DasonA Kapoor
Nov 6, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N PécuchetS Oudard
Oct 12, 2016·Journal of Pathology and Translational Medicine·Gilhyang KimKyung Chul Moon
Feb 10, 2017·Advances in Anatomic Pathology·An Na SeoJae Y Ro
May 13, 2017·Urologic Oncology·Wilson SuiGuarionex Joel DeCastro
Dec 30, 2017·Molecular and Clinical Oncology·Kosuke MizutaniTakashi Deguchi
Feb 23, 2018·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Anissa MoktefiYves Allory
Apr 18, 2018·Pathology International·Jaime A SinghSteven Christopher Smith
May 31, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antonio C WolffMitchell Dowsett
Jun 23, 2018·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Xinan ShengJun Guo
Nov 9, 2018·Medicine·Shotaro YasuokaYukihiro Kondo
Mar 14, 2019·Journal of the National Comprehensive Cancer Network : JNCCN·Michael KarassBishoy M Faltas
Jan 8, 2020·Journal of the National Comprehensive Cancer Network : JNCCN·Tianhong Li
Jan 18, 2020·International Cancer Conference Journal·Kyohei WatanabeHideaki Miyake
Jul 29, 2020·Clinical Genitourinary Cancer·Nicholas J VogelzangScott S Tykodi
Aug 10, 2020·Medicine·Kenta TakahashiSadakatsu Ikeda
Aug 22, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen R D JohnstonWilliam J Gradishar
Aug 28, 2020·Frontiers in Oncology·Jacob J AdashekShumei Kato